CVS Health Co. (NYSE:CVS) Shares Sold by Court Place Advisors LLC

Court Place Advisors LLC cut its stake in shares of CVS Health Co. (NYSE:CVS) by 1.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 51,018 shares of the pharmacy operator’s stock after selling 894 shares during the quarter. CVS Health makes up approximately 1.3% of Court Place Advisors LLC’s portfolio, making the stock its 19th biggest position. Court Place Advisors LLC’s holdings in CVS Health were worth $4,028,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Live Oak Investment Partners acquired a new position in shares of CVS Health during the fourth quarter worth about $25,000. Atticus Wealth Management LLC grew its position in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 219 shares in the last quarter. Cornerstone Planning Group LLC boosted its holdings in CVS Health by 111.5% in the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 243 shares in the last quarter. PCA Investment Advisory Services Inc. acquired a new position in CVS Health in the second quarter valued at approximately $37,000. Finally, ZRC Wealth Management LLC boosted its holdings in CVS Health by 400.0% in the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after purchasing an additional 400 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a report on Wednesday, April 10th. Piper Sandler upped their price target on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Royal Bank of Canada lowered their price target on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. Finally, Barclays began coverage on CVS Health in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price objective for the company. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Price Performance

CVS stock traded down $0.45 on Wednesday, reaching $68.58. 8,098,555 shares of the company’s stock were exchanged, compared to its average volume of 10,906,099. The stock has a fifty day moving average of $75.68 and a 200-day moving average of $73.77. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25. The firm has a market cap of $86.44 billion, a PE ratio of 10.69, a P/E/G ratio of 0.91 and a beta of 0.52. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The firm had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. CVS Health’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.99 earnings per share. As a group, equities analysts predict that CVS Health Co. will post 8.32 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.88%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is 41.18%.

Insider Buying and Selling at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.24% of the stock is owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.